StockNews.com started coverage on shares of Pulmatrix (NASDAQ:PULM – Free Report) in a research note issued to investors on Saturday morning. The firm issued a hold rating on the biotechnology company’s stock. Pulmatrix Stock Performance Shares of NASDAQ PULM opened at $1.80 on Friday. Pulmatrix has a one year low of $1.64 and a one […]